风险人群的螺旋计转变以及一般人群中进展为慢性阻塞性肺病的风险
Yong Suk Jo1, Chin Kook Rhee1, Sang Hyuk Kim2
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Archivos de bronconeumologia
|June 20, 2024
概括
患有慢性阻塞性肺病前期 (COPD) 和保持比率受损螺旋计 (PRISm) 的个人患COPD的风险更高. 这些情况预测肺功能下降的速度更快,气流阻塞的可能性增加.
科学领域:
- 肺部病理学 肺部病理学
- 流行病学 流行病学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 慢性阻塞性肺病 (COPD) 具有重大的社会经济负担.
- 了解从危险状态到COPD的过渡对于公共卫生至关重要.
- 预期人口数据为疾病进展提供了洞察力.
研究的目的:
- 确定导致风险人群患上COPD进展的因素.
- 分析COPD前和PRISM组中的肺功能下降.
- 评估发展空气流阻塞 (AFO) 的风险.
主要方法:
- 使用了韩国基因组流行病学研究 (KoGES) 数据库.
- 通过症状和放射学发现定义了COPD前的情况.
- 使用螺旋计标准 (FEV1/FVC比率≥70%,FEV1<80%) 定义保存比率受损螺旋计 (PRISm).
主要成果:
- 4762个人分析了纵向数据.
- 前COPD组显示肺功能下降速度更快;PRISM组显示下降速度更慢.
- 前COPD和PRISm显著增加了患COPD的风险 (分别为OR 1.80和4.26).
结论:
- 预COPD和PRISm表现出不同的肺功能变化模式.
- 前COPD和PRISm都是未来COPD发展的重要预测因素.
- 心血管并发症可能会影响PRISm和空气流阻塞之间的关系.
相关概念视频
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
COPD: Pathogenesis and Clinical Features
258
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
258
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


